BioAtla, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
BCAB Company Description
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
BCAB Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view BCAB Smart Score
Score Breakdown
BCAB Company Description
Show More
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of BCAB by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by BCAB's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of BCAB in WallStreetBets Daily Discussion
BCAB News
Recent insights relating to BCAB
CNBC Recommendations
Recent picks made for BCAB stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in BCAB
Corporate Flights
Flights by private jets registered to BCAB
Our Analysis